CUSIP 04683R106COMAVIRQ4 2025
50 filings · latest Feb 9, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 9.68M | $34.55M |
| 2 | Blackrock, Inc. | 8.49M | $30.31M |
| 3 | Bml Capital Management, LLC | 7.49M | $26.74M |
| 4 | Tang Capital Management LLC | 4.81M | $17.19M |
| 5 | Vanguard Group Inc | 4.23M | $15.09M |
| 6 | Bain Capital Life Sciences Investors, LLC | 2.49M | $8.87M |
| 7 | Geode Capital Management, LLC | 1.84M | $6.57M |
| 8 | State Street Corp | 1.78M | $6.37M |
| 9 |
| 4 | May 14, 2025 | Jpm Partners LLC | 13G/A | 11.0% | 8.88M | SEC |
| 5 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 7.1% | 6.08M | SEC |
| 6 | Apr 17, 2025 | Radoff Family Foundation | 13D/A | 4.0% | — | SEC |
| 7 | Mar 21, 2025 | Radoff Family Foundation | 13D/A | 3.6% | — | SEC |
| 8 | Mar 4, 2025 | Radoff Family Foundation | 13D | 3.3% | — | SEC |
| 9 | Feb 14, 2025 | Ecor1 Capital, LLC | 13G/A | 4.0% | — | SEC |
| 10 | Dec 16, 2024 | Bml Investment Partners, L.P. | 13D | 8.5% | — | SEC |
See the full Schedule 13D/13G history for Atea Pharmaceuticals Inc.
Unlock full history| 1.37M |
| $4.90M |
| 10 | Jpmorgan Chase & Co | 1.35M | $4.81M |